usdept depart health human servic usdept usbureau food drug administr usbureau cfrno 21 cfr part 74 cfrno rindock docket 92c0294 rindock list color addit subject certif dc green 5 agenc agenc food drug administr hh agenc action action final rule action summari summari food drug administr fda amend color addit regul provid safe use dc green 5 color drug cosmet intend use area eye action respons petit file cosmet toiletri fragranc associ ctfa summari date date effect septemb 12 1994 except provis may stay file proper object written object request hear septemb 9 1994 date address address submit written object docket manag branch hfa305 food drug administr rm 123 12420 parklawn dr rockvil md 20857 address inform contact robert l martin center food safeti appli nutrit hfs217 food drug administr 200 c st sw washington dc 20204 2022549519 supplem supplementari inform introduct notic publish feder regist august 11 1992 57 fr 35833 fda announc color addit petit cap 6c0204 file ctfa 1101 17th st nw suit 300 washington dc 20036 petit propos color addit regul dc green 5 amend provid safe use dc green 5 color drug cosmet intend use area eye petit file section 706 current section 721 feder food drug cosmet act act 21 u c 376 current 21 u c 379e ii regulatori histori regulatori histori dc green 5 summar final rule publish feder regist june 4 1982 47 fr 24278 final rule fda perman list dc green 5 use drug cosmet exclud use area eye action taken respons color addit petit cap 8c0084 iii definit section 70 3 21 cfr 70 3 defin term area eye area enclos within circumfer supra orbit ridg infra orbit ridg includ eyebrow skin eyebrow eyelid eyelash conjunctiv sac eye eyebal soft areolar tissu lie within perimet infra orbit ridg 21 cfr 70 5 state list certif color addit shall consid author use color addit articl intend use area eye unless list certif color addit specif provid use petition request use dc green 5 expand includ drug cosmet use area eye iv color addit dc green 5 princip disodium salt 2 2 9 10 dihydro 9 10 dioxo 1 4 anthracenediyl diimino bi 5 methylbenzenesulfon acid ca reg 4403901 manufactur dc green 5 accomplish sulfon dc green 6 fume sulfur acid dc green 6 start materi manufactur process possibl exist chemic use synthesi dc green 6 may present minor amount dc green 5 dc green 6 form chemic react one molecul quinizarin two molecul p toluidin signific compon weisburg et al demonstr p toluidin carcinogen mice ref 1 residu amount reactant p toluidin relat manufactur aid commonli found among constitu mani color addit presenc constitu howev uniqu color addit numer contamin unavoid present chemic product even highli purifi reagent grade chemic although dc green 5 shown caus cancer contain minor amount carcinogen impur p toluidin carcinogen p toluidin discuss final rule publish feder regist june 4 1982 47 fr 24278 perman list dc green 5 use drug cosmet exclud use area eye v determin safeti section 721 b 4 act 21 u c 379e b 4 call gener safeti claus color addit color addit cannot list particular use unless fair evalu data avail fda establish color addit safe use fda color addit regul 70 3 defin safe convinc evid establish reason certainti harm result intend use color addit anticanc delaney claus color addit amend section 721 b 5 b act provid noningest color addit shall deem unsaf shall list test appropri evalu safeti addit use found induc cancer man anim importantli howev delaney claus appli addit constitu addit addit shown caus cancer contain carcinogen impur addit properli evalu gener safeti claus use risk assess procedur determin whether reason certainti harm result propos use addit scott v fda 728 f 2d 322 6th cir 1984 vi safeti petit use addit fda estim data submit relev inform exposur dc green 5 use drug cosmet intend use area eye 0 56 milligram per person per day mg p base upon maximum frequenc applic maximum quantiti appli fda ordinarili consid chronic toxicolog test necessari determin safeti addit whose use result low exposur level ref 2 agenc requir test although agenc normal requir test chronic studi support current list use dc green 5 avail agenc file fda safeti evalu propos use color addit drug cosmet intend use area eye includ consider studi two year carcinogen studi dc green 5 show indic carcinogen fda evalu safeti addit gener safeti claus consid avail data agenc use risk assess procedur estim upper bound limit risk present p toluidin carcinogen chemic may present impur addit risk evalu chemic two aspect 1 assess exposur impur propos use addit 2 extrapol risk observ anim bioassay condit probabl exposur human fda estim maximum total lifetim exposur p toluidin result use dc green 5 drug cosmet intend use area eye compli applic specif 8 4 nanogram ng p exposur estim base use color addit eyebrow pencil eyelin eye shadow eye lotion eye makeup remov mascara eye cream eye shadow base eye stick agenc use data report nation cancer institut demonstr p toluidin carcinogen male femal charl river cd1 ham icr deriv mice caus increas incid hepatoma liver tumor ref 1 estim upper bound limit lifetim human risk exposur chemic stem propos use dc green 5 color addit drug cosmet intend use area eye ref 3 base potenti exposur 8 4 ng p fda estim upper bound limit individu lifetim risk potenti exposur p toluidin propos use dc green 5 color addit eye area drug cosmet 2 x 10 9 2 1 billion ref 4 moreov fda point earlier determin risk exposur p toluidin use dc green 5 agenc calcul upper bound limit individu lifetim risk 1 30 million 1 300 million rang 47 fr 24278 thu use dc green 5 eye area drug cosmet increas risk way agenc also point numer conserv assumpt use calcul exposur estim actual lifetim averag individu exposur p toluidin expect substanti less worst case exposur therefor actual upper bound limit risk would less cite thu agenc conclud reason certainti harm exposur p toluidin might result propos use dc green 5 color drug cosmet intend use area eye evalu safeti propos use subject addit fda also consid safeti data submit previous support current list use dc green 5 toxic studi dc green 5 involv dog rat mice includ acut oral toxic studi subchron studi chronic toxic studi anim expos color addit diet skin applic reproduct toxic studi studi produc evid dc green 5 would unsaf petit use addit fda evalu ocular toxic studi petition provid support propos use dc green 5 drug cosmet intend use area eye almost anim free sign ocular irrit effect note anim exhibit irrit slight conjunctiv red discharg irrit seen sporad control test anim base review studi fda find signific advers clinic find ocular irrit studi vii conclus safeti base upon avail toxic data relev consider discuss fda conclud reason certainti harm result use dc green 5 color addit drug cosmet intend use area eye agenc also conclud basi avail data color addit perform intend technic effect thu suitabl petit use agenc therefor amend 74 1205 c 2 74 2205 b color addit regul provid use dc green 5 drug cosmet intend use area eye b specif dc green 5 current produc certifi color addit use drug cosmet exclud use area eye amount consist current good manufactur practic accord 21 cfr part 80 base upon low level exposur p toluidin result current specif dc green 5 74 1205 74 2205 21 cfr 74 1205 74 2205 agenc conclud specif list 74 1205 adequ ensur safe use color addit control amount p toluidin may exist impur color addit use drug cosmet intend use area eye viii inspect document accord 71 15 21 cfr 71 15 petit document fda consid reli upon reach decis approv petit avail inspect center food safeti appli nutrit address appoint inform contact person list provid 71 15 agenc delet document materi avail public disclosur make document avail inspect ix environment impact agenc care consid potenti environment effect action fda conclud action signific impact human environ environment impact statement requir agenc find signific impact evid support find contain environment assess may seen docket manag branch address 9 4 p monday friday x object person advers affect regul may time septemb 9 1994 file docket manag branch address written object thereto object shall separ number number object shall specifi particular provis regul object made ground object number object hear request shall specif state failur request hear particular object shall constitut waiver right hear object number object hear request shall includ detail descript analysi specif factual inform intend present support object event hear held failur includ descript analysi particular object shall constitut waiver right hear object three copi document shall submit shall identifi docket number found bracket head document object receiv respons regul may seen docket manag branch 9 4 p monday friday fda publish notic object agenc receiv lack thereof feder regist xi refer follow refer place display docket manag branch address may seen interest person 9 4 p monday friday 1 weisburg e k et al test twenti one environment aromat amin deriv long term toxic carcinogen journal environment patholog toxicolog 2 325356 1978 2 kokoski c j regulatori food addit toxicolog chemic safeti regul complianc edit f homburg j k marqui karger ny pp 2433 1985 3 memorandum confer cancer assess committe para toluidin februari 24 1981 4 report quantit risk assess committe estim upper bound lifetim risk para toluidin dc green 5 use request cap 6c0204 cosmet toiletri fragranc associ septemb 28 1993 list subject 21 cfr part 74 color addit cosmet drug therefor feder food drug cosmet act author deleg commission food drug 21 cfr part 74 amend follow part 74_list color addit subject certif 1 author citat 21 cfr part 74 continu read follow author sec 201 401 402 403 409 501 502 505 601 602 701 721 feder food drug cosmet act 21 u c 321 341 342 343 348 351 352 355 361 362 371 379e 2 section 74 1205 amend revis paragraph c 2 read follow 74 1205 dc green 5 c 2 dc green 5 may safe use color drug gener includ drug intend use area eye amount consist current good manufactur practic 3 section 74 2205 amend revis paragraph b read follow 74 2205 dc green 5 b use restrict dc green 5 may safe use color cosmet gener includ cosmet intend use area eye amount consist current good manufactur practic date august 4 1994 supplem signer michael r taylor signer signjob deputi commission polici signjob frfile fr doc 9419483 file 8994 8 45 frfile bill bill code 416001f bill